Perspectives: Jellyfish Publication of an exciting new human clinical trial of proprietary KollaJell™ collagen peptide formulation
Nyenta.com/10313390

TEMECULA, Calif. - Nyenta -- Jellyfish Publication-Certified Nutraceuticals, Inc.

Gerald M. Haase, M.D.
Clinical Professor of Surgery, University of Colorado School of Medicine, Aurora, CO.

Neil E. Wolkodoff, PhD
Medical Program Director, Colorado Center for Health and Sports Science, Denver, CO.
May 16, 2025

Certified Nutraceuticals, Inc., a research and product development enterprise in Pauma Valley, California, U.S.A., announces the publication of an exciting new human clinical trial of its proprietary KollaJell™ collagen peptide formulation.

The research study of this unique jellyfish collagen-based supplement was published in the peer-reviewed medical source, the Journal of Clinical Research and Reports. The strength of this prospective, randomized trial is the distinctive utilization of a panel of brain function metrics from two robust, validated instruments, including a computerized neurocognitive test battery and an electroencephalographic (EEG) profile of voltage activation and wave phase pattern. Instead of evaluating only one or two parameters, this investigation assessed seven domains of cognitive function in 23 subjects who consumed KollaJell™ for a period of eight weeks.

More on Nyenta.com

• Andrew Finkelstein Named President of NYSTLA at Gala Featuring Rep. Dan Goldman
• Yonkers: MAYOR MIKE SPANO TO OPEN COOLING CENTERS CITYWIDE STARTING JUNE 23
• Dr. Jacqueline West Honored as Best Dentist in JAX by Folio Weekly
• Buffalo Producer The MarTian SMG Earns 5x Gold Certification for Key Glock's "Dirt"
• Exciting News: Pivotal Health Solutions Acquires Revolutionary Portable Parallel Bars

The outcomes were clinically relevant, and all were statistically analyzed and achieved statistical significance. Standard scores matched for age and gender improved in all metrics regardless of the functional status of where the subject started. The parameters included compositive memory, neurocognitive index, visual memory, executive function and verbal memory. Under EEG monitoring conditions, the mean total reaction time and the trail-making composite test times also decreased dramatically. Topographic brain images showed voltage activation in the brain regions associated with sensory input and processing function. There were no adverse effects of consuming the supplement in any subject at any time during the study.

The importance of this pilot trial is the demonstration of a particularly extensive spectrum of beneficial results from the proprietary formulation compared to competing products that, even if helpful, provide only limited effects. In addition, the use of a marine-based natural collagen was superior to the usual animal-based products and the patented extraction process provided a greater platform of collagen types and a uniquely effective amino acid composition. This human clinical trial reinforces the concept that Certified Nutraceuticals KollaJell™ is a safe and beneficial collagen supplement that supports cognitive domains and memory and is applicable to a wide audience of potential consumers, regardless of their initial brain function status.

More on Nyenta.com

• Canadian Pavilion Returns to Summer Fancy Food Show, New York, Showcasing Premier Specialty Products
• Faruqi & Faruqi Reminds Elevance Health Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 11, 2025 - ELV
• Miboxer Achieved New Goal in GILE 2025
• Jeopardy!'s Ken Jennings Headlines National Mensa Event
• Mensa Foundation Prize Awarded to Neuroscientist-Pianist

The actual medical study is available as a free open-access publication at https://www.auctoresonline.org/article/effects-of-a-jellyfish-collagen-based-amino-acid-supplement-on-cognitive-function-and-memory-a-pilot-investigation

For further information about the product or study, please contact:

Sara Alkayali at (951) 600-3899 or email: salkayali@certifiednutra.com